Upload
ali-riza
View
215
Download
3
Embed Size (px)
Citation preview
ORIGINAL ARTICLE
Assessment of atrial electromechanical delay in patientswith migraine
Asuman Celikbilek • Savas Sarikaya •
Gokmen Zararsiz • Nermin Tanik • Ali Riza Erbay
Received: 22 October 2013 / Accepted: 17 December 2013
� Belgian Neurological Society 2013
Abstract Evidence suggests that symptoms of migraine
are related to the involvement of the autonomic nervous
system. Data on atrial conduction system are limited in
migraineurs. We aimed to assess atrial electromechanical
delay using tissue Doppler imaging (TDI) in patients with
migraine. Forty-five migraine patients and age- and sex-
matched 26 control subjects were enrolled in the study. All
the patients and controls underwent resting surface elec-
trocardiogram (ECG) and TDI. The maximum P-wave
duration (Pmax), minimum P-wave duration (Pmin) and
P-wave dispersion (Pd) were measured from the 12-lead
ECG. Atrial conduction time was determined from the
lateral mitral annulus (PA lateral), septal mitral annulus
(PA septal), and lateral tricuspid annulus (PA tricuspid) by
TDI. Interatrial (PA lateral–PA tricuspid) and intraatrial
(PA septal–PA tricuspid) electromechanical delays were
calculated. Pd was significantly higher in migraine patients
than in controls (p \ 0.05), whereas Pmax and Pmin were
not different between both groups (p [ 0.05). PA lateral
and PA septal durations were significantly higher in
migraine patients than in controls (p \ 0.001 and p \ 0.05,
respectively). However, PA tricuspid duration was similar
between the groups (p [ 0.05). Both interatrial and intra-
atrial conduction times were delayed in migraineurs as
compared to the controls (p \ 0.001). Interatrial delay and
intraatrial delay variables were found as an independent
risk factors separately on predicting atrial conduction
abnormalities in migraineurs. An interatrial delay of 18 ms
and an intraatrial delay of 5 ms were found to be cutoff
values in ROC analysis (p \ 0.001). This is the first report
to provide a hypothetical suggestion that there is an atrial
electromechanical delay in patients with migraine.
Keywords Atrial electromechanical delay � Autonomic
nervous system � Electrocardiogram � Migraine � P-wave
dispersion � Tissue Doppler imaging
Introduction
Migraine is a primary, chronic intermittent neurovascular
disorder characterized by episodic headache, vegetative
symptoms, and in a minority of patients, by other neuro-
logical signs such as aura [1]. Evidence suggests that
symptoms of migraine are related to the involvement of the
autonomic nervous system (ANS) [2, 3]. The ANS has also
known to play a potentially important role in the occur-
rence of cardiac repolarization due to the rich autonomic
innervation of the heart [3]. Dysfunction of the ANS may,
therefore, cause cardiac repolarization abnormalities [3, 4].
Within this context, the ANS is considered to be involved
in the conduction characteristics, although the precise
mechanisms underlying this interaction are not clear [3–5].
Then, we may speculate that patients with migraine could
have higher atrial conduction abnormalities, as a substrate
for cardiac arrhythmias, than those without migraine.
However, the data are limited on this ground [4, 6, 7].
A. Celikbilek (&) � N. Tanik
Department of Neurology, Medical School, Bozok University,
Yozgat 66200, Turkey
e-mail: [email protected]
S. Sarikaya � A. R. Erbay
Department of Cardiology, Medical School, Bozok University,
Yozgat, Turkey
G. Zararsiz
Department of Biostatistics, Medical School, Hacettepe
University, Ankara, Turkey
123
Acta Neurol Belg
DOI 10.1007/s13760-013-0273-8
With recent developments, it is possible to evaluate the
atrial conduction abnormalities using tissue Doppler
imaging (TDI) and two simple electrocardiographic
markers, maximum P-wave duration (Pmax) and P-wave
dispersion (Pd) [8]. M-mode, Doppler, and finally TDI,
which is a noninvasive method alternative to invasive
electrophysiological studies, have been shown to be a
useful technique in evaluating conduction characteristics
[9]. To date, Pmax and Pd parameters were evaluated in
patients with migraine [6, 7], but TDI findings have not
been studied in migraineurs. For the first time in literature,
we aimed to assess atrial electromechanical delay using
TDI in patients with migraine.
Methods
Study population
Forty-five newly diagnosed migraine patients and age- and
sex-matched 26 control subjects ranging 18–50 years were
enrolled in this cross-sectional prospective study. Patients
with malignancy, chronic renal, hepatic or autoimmune
diseases, diabetes mellitus, thyroid disease, anemia, elec-
trolyte imbalance, pregnancy, morbid obesity, smoking,
alcohol consumption, hyperlipidemia, hypertension, medi-
cations known to alter cardiac conduction, a history of
coronary artery disease, atrial fibrillation or other arrhyth-
mias and poor echocardiographic imaging were excluded
from the study. Migraine diagnosis was settled according to
the International Classification of Headache Disorders-II
diagnostic criteria [10]. Twenty-nine patients had migraine
with aura, while the rest had migraine without aura. The
control subjects were enrolled as healthy individuals who
had no headache of any kind. The patient’s medical history,
physical and neurological examinations were performed by
the same neurologist. Migraine patients were evaluated
according to the headache characteristics including aura,
severity, frequency and duration of the migraine attack and
the duration of the disease. Based on visual analog scale,
the headache was defined as mild (score 1–3), moderate [4–
6], severe (score 7–8) or very severe (score 9–10) [11].
Migraine headache attack frequency was noted as the
number of attacks per month [12]. Duration of the head-
ache attack was defined as hours whereas disease duration
as the year. All patients were studied during the headache-
free period. These subjects were not on any medication.
Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) were measured for each patient. Body mass index
(BMI) was calculated as weight in kilograms divided by
the square of height in meters [13]. Using standard labo-
ratory methods, baseline venous blood samples were
obtained from the antecubital vein after an overnight fast
for measurements of plasma glucose, total cholesterol
(TC), low-density lipoprotein (LDL) cholesterol, high-
density lipoprotein (HDL) cholesterol, triglycerides (TG),
creatinine, alanine aminotransferase (ALT), thyroid stim-
ulating hormone and complete blood count which were
routinely performed for each patient. The study protocol
was approved by the Bozok University Local Research
Ethics Committee and written informed consent was
obtained from all patients.
Electrocardiographic analysis
All subjects underwent a 12-lead electrocardiogram (ECG)
recording after a 20 min resting period in supine position at
a paper speed of 50 mm/s and 2 mV/cm standardization.
To decrease the error, P-wave duration was measured
manually in all simultaneously recorded 12 leads of the
surface ECG by two qualified investigators unaware of the
study hypothesis. In each lead, the mean values for the
three complexes were calculated. The onset of the P-wave
was defined as the point of first visible upward departure
from baseline for positive waveforms and as the point of
first downward departure from the baseline for negative
waveforms. The return to the baseline was considered to be
the end of the P-wave. The Pmax measured in any of the 12
leads of the surface ECG was used as the longest atrial
conduction time. The difference between Pmax and the
minimum P-wave duration (Pmin) was calculated and
defined as Pd (Pd = Pmax-Pmin). Intraobserver and inter-
observer coefficients of variation were 3.0 and 3.4 % for
Pmax, and 3.5 and 3.8 % for Pd, respectively.
Echocardiographic analysis
All patients were evaluated by transthoracic two-dimen-
sional, M-mode, pulsed-wave, continuous wave, color
flow, and TDI. The echocardiographic measurements and
analysis were performed with the Aloka system (Aloka,
Japan) by a 2–4 MHz transducer at a depth of 16 cm, by a
cardiologist who was blinded to the clinical details and
results of the other investigations of each patient and
control. During echocardiography, 1-lead ECG was recor-
ded continuously. All patients were imaged while resting at
the left lateral decubitus position. M-mode measurements
were performed according to the criteria of American
Society of Echocardiography [14]. Three consecutive
cycles were averaged for every parameter. Left atrial
diameter (LAD) and left ventricular ejection fraction
(LVEF) were measured by M-mode echocardiography.
LVEF was estimated by Simpson’s rule [15]. TDI was
performed by the same echocardiograph machine, adjust-
ing the spectral pulsed Doppler signal filters until a Nyquist
limit of 15–20 cm/s was reached and using the minimal
Acta Neurol Belg
123
optimal gain. The monitor sweep speed was set at
50–100 mm/s to optimize the spectral display of myocar-
dial velocities. In an apical four-chamber view, the pulsed
Doppler sample volume was placed at the level of LV
lateral mitral annulus, septal mitral annulus, and lateral
tricuspid annulus. The sampling window was positioned as
parallel as possible to the myocardial segment of interest to
ensure the optimal angle of imaging. The time interval
from the onset of the P-wave on surface ECG to the
beginning of the late diastolic wave (Am wave), which is
called atrial electromechanical coupling (PA), was
obtained from the lateral mitral annulus (PA lateral), septal
mitral annulus (PA septal), and lateral tricuspid annulus
(PA tricuspid), respectively. The difference between PA
lateral and PA tricuspid was defined as interatrial electro-
mechanical delay (PA lateral–PA tricuspid), and the dif-
ference between PA septal and PA tricuspid was defined as
intraatrial electromechanical delay (PA septal–PA tricus-
pid). Values were averaged over three consecutive beats.
Intraobserver variability was 5.3 % for PA lateral, 5.8 %
for PA septal, and 5.3 % for PA tricuspid, respectively.
Interobserver variability was 5.0 % for PA lateral, 5.2 %
for PA septal, and 5.7 % for PA tricuspid, respectively.
Statistical analysis
The Shapiro–Wilk’s test, histograms, and q–q plots were
used to test the normality of the data, and Levene’s test was
used to assess variance homogeneity. A two-way inde-
pendent-sample t tests, Welch t test and Mann–Whitney
U tests were used to compare differences between contin-
uous variables and Fisher’s exact test was used to assess
the differences between categorical variables. Pearson
correlation was used to examine the relationship between
laboratory data, electrophysiological findings and headache
characteristics including aura, attack severity, frequency,
duration, and the disease duration. Univariate and multiple
logistic regression analyses were conducted to identify the
risk factors of atrial conduction abnormalities in migrai-
neurs. Odds ratios (OR) are calculated with 95 % confi-
dence intervals (CI). Only for the parameters of creatinine
and LAD, we have limited values of which the cutoff
values were used to calculate OR. Significant variables in
univariate analysis were included into multiple models and
backward elimination procedure was applied using likeli-
hood ratio statistic. Correlated variables were considered
separately in multiple logistic regression models. More-
over, receiving operating characteristic (ROC) curve
analyses were applied and the area under these curves
(AUC) was calculated with 95 % CI for PA lateral, PA
septal, interatrial delay, intraatrial delay, Pd variables and
compared between them. Also, cutoff values were deter-
mined for each variable and sensitivity, specificity, positive
predictive value, negative predictive value diagnostic
measures (with 95 % CI) and Kappa test statistic were
calculated. Values are expressed as frequencies and per-
centages, means and standard deviations, or medians and
interquartile ranges. Analyses were conducted using R
3.0.0 software. A p probability level\5 % was considered
as statistically significant.
Results
The demographic and laboratory data of the migraine and
control patients are summarized in Table 1. With respect to
age and gender, no significant difference was found
between the two groups (p [ 0.05). Similarly, there was no
significant association between the parameters of BMI,
SBP, DBP in migraine patients as compared with the
controls (p [ 0.05). The laboratory results revealed that
fasting glucose, renal and liver function tests, complete
blood count and thyroid stimulating hormone did not sig-
nificantly differ in migraineurs as compared to the controls
(p [ 0.05). Regarding lipid profile, total cholesterol was
only significantly higher in migraine patients than in con-
trols (p \ 0.05).
The electrocardiographic and echocardiographic mea-
surement results are listed in Table 2. Pd was significantly
higher in migraine patients than in controls (p \ 0.05),
whereas Pmax and Pmin were not different between the two
groups (p [ 0.05). The heart rates, LVEF and LAD were
similar between the two groups (p \ 0.05). PA lateral and
PA septal durations were significantly higher in patients
with migraine as compared to the control group (p \ 0.001
and p \ 0.05, respectively). However, PA tricuspid dura-
tion was similar between both groups (p [ 0.05). Both
interatrial and intraatrial conduction times were delayed in
patients with migraine when compared with the controls
(p \ 0.001). We applied four multiple logistic regression
models due to high correlations between PA lateral-PA
septal (r = 0.791, p \ 0.001) and between interatrial
delay-intraatrial delay (r = 0.680, p \ 0.001). First model
contained the PA lateral-interatrial delay pair and the other
significant variables in univariate analysis. Second model
contained the PA lateral-intraatrial delay pair and the other
significant variables in univariate analysis. Third model
contained the PA septal-interatrial delay pair and the other
significant variables in univariate analysis. Last model
contained the PA septal-intraatrial delay pair and the other
significant variables in univariate analysis. After multiple
logistic regression results, interatrial delay and intraatrial
delay variables were found as an independent risk factors
separately on predicting atrial conduction abnormalities in
migraine patients [OR and 95 % CI are 1.24 (1.11–1.38)
and 1.52 (1.17–1.96), respectively, Table 2]. ROC analysis
Acta Neurol Belg
123
was applied for PA lateral, PA septal, interatrial delay,
intraatrial delay and Pd variables (Fig. 1). AUC values
were found as 0.76 (0.65–0.86), 0.66 (0.54–0.77), 0.83
(0.73–0.91), 0.80 (0.69–0.89) and 0.67 (0.55–0.78),
respectively, as presented in Table 3. An interatrial delay
of 18 ms and an intraatrial delay of 5 ms were found to be
cutoff values with a sensitivity and specificity of 0.87
(0.73–0.95) and 0.65 (0.44–0.83), 0.89 (0.76–0.96) and
0.62 (0.41–0.80) to predict atrial conduction abnormalities,
respectively, in the ROC analysis (j = 0.534 and
j = 0.526, respectively, p \ 0.001, Table 3). Also, with
an alternative cutoff value of 22 ms for interatrial delay,
sensitivity is calculated as 0.73 (0.58–0.85) and specificity
as 0.88 (0.70–0.97).
Based on correlation analysis, no correlation was
detected between the electrophysiological findings and
headache characteristics (p [ 0.05).
Discussion
The salient findings of our study were as follows: (1) PA
lateral and PA septal durations and Pd were significantly
higher in patients with migraine than in controls; (2)
interatrial and intraatrial conduction times were delayed in
patients with migraine as compared to the controls; (3)
interatrial delay and intraatrial delay variables were inde-
pendent parameters in migraine patients; (4) an interatrial
delay of 18 ms and an intraatrial delay of 5 ms were found
to be cutoff values with a sensitivity and specificity of 0.87
and 0.65, 0.89 and 0.62, respectively, in ROC analysis.
The pathophysiology of migraine is not completely
understood, but it is assumed that migraine is commonly
associated with a variety of autonomic accompaniments
such as nausea, vomiting, pallor, flushing, piloerection and
diaphoresis [2]. This may be explained by varied auto-
nomic dysregulation, perhaps the result of an imbalance
between the sympathetic and parasympathetic systems [3].
There are both sympathetic and parasympathetic nerve
fibers in venous and perivenous tissue. The interaction
between the sympathetic and parasympathetic systems,
particularly changes in sympathovagal balance, may con-
tribute to the various clinical features of migraineurs [3, 5].
The ANS has also known to play an important role in the
occurrence of cardiac repolarization due to the rich auto-
nomic innervation of the heart [3]. Dysfunction of the ANS
may, therefore cause cardiac repolarization abnormalities
[3, 4]. Then, the ANS is considered to be involved in the
conduction characteristics [3–5]. Recent studies have
demonstrated that Pd and Pmax, electrocardiographic
markers of atrial conduction abnormalities, get longer in
various rheumatologic disorders, including scleroderma,
rheumatoid arthritis, and Behcet’s disease [16–19]. In
addition, disrupted autonomic innervation of the heart and
coronary arteries in migraine patients was linked to the
possible ECG abnormalities, particularly PR and corrected
Table 1 Demographic and laboratory data of migraine patients and controls
Variable Control (n = 26) Migraine (n = 45) p OR (95 % CI)
Age (years) 30 ± 7.01 33.47 ± 8.17 0.074 1.06 (0.99–1.13)
Gender (male/female) 3 (12.0)/23 (88.0) 3 (6.7)/42 (93.3) 0.999 0.86 (0.13–5.50)
BMI (kg/m2) 25.31 (21.95–26.8) 26.12 (23.4–27.1) 0.110 1.16 (0.96–1.39)
SBP (mmHg) 110 (100–120) 110 (100–120) 0.576 0.99 (0.95–1.03)
DBP (mmHg) 60 (60–80) 70 (60–70) 0.892 0.99 (0.94–1.05)
TC (mg/dL) 171.62 ± 35.21 188.42 ± 27.5 0.029 1.02 (1.00–1.04)
LDL-C (mg/dL) 106.38 ± 26.37 115.91 ± 20.81 0.097 1.02 (0.99–1.04)
HDL-C (mg/dL) 43.5 (40–48) 42 (40–50) 0.928 1.02 (0.96–1.08)
TG (mg/dL) 112 ± 34.71 102.53 ± 37.89 0.300 0.99 (0.98–1.01)
Fasting glucose (mg/dL) 88 (85–91) 87 (83–89) 0.245 0.94 (0.86–1.03)
Creatinine (mg/dL) (\0.6/[0.6) 0.6 (0.6–0.8) 0.6 (0.5–0.7) 0.065 1.62 (0.60–4.42)
WBC (103/mm3) 6.95 (5.9–9) 7.4 (6.6–8.2) 0.971 0.97 (0.67–1.42)
Hemoglobin (mg/dL) 13.25 (12.8–14.5) 13.5 (12.5–14.4) 0.844 0.94 (0.64–1.38)
Platelet (103/mm3) 261 (228–322) 257 (219–307) 0.716 1.00 (0.99–1.01)
ALT (IU/L) 15.81 ± 5.19 16.31 ± 7.89 0.772 1.01 (0.94–1.09)
TSH (uIU/mL) 2.05 ± 1.12 1.89 ± 0.95 0.526 0.86 (0.53–1.38)
Values are expressed as n (%), mean ± SD or median (1st–3rd quartile)
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, LDL-C low-density lipoprotein
cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride, WBC white blood cells, ALT alanine aminotransferase, TSH thyroid
stimulating hormone
Acta Neurol Belg
123
QT interval lengthening during a migraine attack [4]. In
parallel, Duru et al. [6] showed that migraine attacks were
associated with a prolonged QT interval and Pd which
could be predictors of arrhythmia. Besides, Kocer et al. [7]
found that Pd, being higher in migraineurs than in controls,
was positively correlated with migraine attack number per
month. In agreement with these reports, the increased Pd
values in our migraine patients may suggest that migrai-
neurs might have an increased risk of developing atrial
rhythm disturbances relative to non-migraineurs.
On the other hand, the prolongation of intraatrial and
interatrial conduction times and the inhomogeneous propa-
gation of sinus impulses are well-known electrophysiologic
characteristics of the atrium prone to fibrillate [20]. In recent
years, interatrial and intraatrial electromechanical delay,
another indicator of cardiac arrhythmias, has been identified
in patients with systemic lupus erythematosus, familial
Mediterranean fever, ankylosing spondylitis and Behcet’s
disease [19, 21–23]. The proposed mechanism in these dis-
orders is the inflammation causing damage involving left
atrial tissue resulting in left atrial fibrosis. To our knowledge,
atrial electromechanical delay has not been evaluated in
patients with migraine before. In concordance with those
reports, we found that interatrial and intraatrial conduction
times were independently delayed in migraineurs. Our
patients were asymptomatic and did not have either any kind
of cardiac arrhythmia or history of beta-blocker usage, which
might influence the conduction characteristics. This may
probably indicate the conduction system involvement in
migraine patients. The actual mechanistic pathway for this
condition is difficult to explain; however, it could be attrib-
utable to the structural and electrophysiologic changes in the
atrial myocardium through the ANS-related effects, result-
ing in the prolonged atrial activation time rather than a part of
an increased atrial size and/or a decreased pump function of
the heart. The similarity for LAD and LVEF between
migraine patients and controls supported this hypothesis. In
contrast, the electrophysiological findings did not correlate
with migraine characteristics, but larger cohorts are needed
to draw any conclusion.
The present study has certain limitations. First, our study
is cross-sectional, hence, we cannot determine a causal link
between migraine and atrial electromechanical delay, and
we lacked follow-up data for future arrhythmic events in
migraineurs, both of which considered together, represent
the greatest limitation of this study. Second, atrial con-
duction time was not examined by invasive electrophysi-
ologic techniques which are the gold standard methods for
this evaluation. Third, we measured the atrial electrome-
chanical delay only in three points at the annulus level,
measurements at different atrial regions might give us more
detailed information about the atrial conduction times.
Fourth, the measurements were done in the headache-free
period, so we were unable to compare the findings during
Table 2 Comparison of the
electrocardiographic and tissue
Doppler echocardiographic
findings of migraine patients
and controls
Values are expressed as n (%),
mean ± SD or median (1st–3rd
quartile)
LVEF Left ventricular ejection
fraction, LAD left atrial
diameter
Variable Control (n = 26) Migraine (n = 45) p OR (95 % CI)
Heart rate (beats/min) 75 (68.7–80) 78 (65–80.5) 0.879 0.99 (0.94–1.05)
LVEF (%) 64 (63–66) 64 (62–66) 0.595 1.08 (0.86–1.35)
LAD (cm) ([3.3/\3.3) 3.3 (3.2–3.3) 3.3 (3.2–3.4) 0.135 2.44 (0.82–7.23)
PA lateral (ms) 55 (48–64) 64 (60–72) \0.001 1.14 (1.06–1.22)
PA septal (ms) 36 (36–50) 48 (42–50) 0.002 1.08 (1.01–1.16)
PA tricuspid (ms) 32.5 (30–46) 39 (32–42) 0.529 1.01 (0.95–1.08)
Interatrial delay (ms) 18.19 ± 4.85 27.38 ± 8.2 \0.001 1.24 (1.11–1.38)
Intraatrial delay (ms) 5.15 ± 2.68 9.33 ± 5.56 0.001 1.52 (1.17–1.96)
Pmax (ms) 93.61 ± 4.84 95.60 ± 6.34 0.173 1.07 (0.97–1.17)
Pmin (ms) 55.69 ± 5.06 53.96 ± 2.66 0.114 0.88 (0.77–1.01)
Pd (ms) 37.81 ± 6.6 41.56 ± 6.03 0.017 1.11 (1.01–1.21)
Fig. 1 Comparison of ROC curves of PA lateral, PA septal,
interatrial delay, intraatrial delay and Pd in patients with migraine
Acta Neurol Belg
123
and after an attack. Fifth, we lacked ambulatory 24 h
Holter recording for the detection of cardiac extrasystole
burden in the study group.
In conclusion, despite the abovementioned limitations,
this is the first report to provide a hypothetical suggestion that
there is an atrial electromechanical delay in patients with
migraine. Indeed, it is usually difficult to measure the con-
duction times in practice. Future large-scale longitudinal
studies that overcome the current study’s limitations will
present a more detailed view of underlying mechanisms of
the tendency for cardiac arrhythmias in patients with
migraine.
Conflict of interest None.
References
1. Thomsen LL, Olesen J (1995) The autonomic nervous system and
the regulation of arterial tone in migraine. Clin Autonom Res
5(5):243–250
2. Peroutka SJ (2004) Migraine: a chronic sympathetic nervous
system disorder. Headache 44(1):53–64 PubMed PMID:
WOS:000187848000009. English
3. Melek IM, Seyfeli E, Duru M, Duman T, Akgul F, Yalcin F
(2007) Autonomic dysfunction and cardiac repolarization
abnormalities in patients with migraine attacks. Med Sci Monit
13(3):RA47–RA49 PubMed PMID: 17325646
4. Aygun D, Altintop L, Doganay Z, Guven H, Baydin A (2003)
Electrocardiographic changes during migraine attacks. Headache
43(8):861–866
5. Cavaco DM (2009) Atrial fibrillation and the autonomic nervous
system: pieces of the puzzle. Revista Portuguesa de Cardiologia.
28(3):259–261 PubMed PMID: 19480308
6. Duru M, Melek I, Seyfeli E, Duman T, Kuvandik G, Kaya H et al
(2006) QTc dispersion and P-wave dispersion during migraine
attacks. Cephalalgia 26(6):672–677
7. Kocer A, Eryilmaz M, Tutkan H, Ercan N, Kucukbayrak ZS
(2012) Higher P-wave dispersion in migraine patients with higher
number of attacks. Sci World J 2012:791460 PubMed PMID:
22666153. Pubmed Central PMCID: 3361318
8. Ozer N, Yavuz B, Can I, Atalar E, Aksoyek S, Ovunc K et al
(2005) Doppler tissue evaluation of intra-atrial and interatrial
electromechanical delay and comparison with P-wave dispersion
in patients with mitral stenosis. J Amer Soc Echocardio
18(9):945–948
9. Deniz A, Sahiner L, Aytemir K, Kaya B, Kabakci G, Le Tokg-
ozoglu L et al (2012) Tissue Doppler echocardiography can be a
useful technique to evaluate atrial conduction time. Cardiol J
19(5):487–493 PubMed PMID: WOS:000311771900008. English
10. Torelli P, Beghi E, Manzoni GC (2004) Appendix to the Interna-
tional classification of headache disorders (2nd edition): application
of diagnostic criteria for tension-type headache. Cephalalgia
24(9):791 PubMed PMID: WOS:000223377900069. English
11. Azapagasi E, Alehan F, Saygi S, Bayraktar N, Yazici AC (2012)
Serum concentrations of neuron-specific enolase in pediatric
migraine. Turk J Pediatr 54(2):150–155 PubMed PMID:
22734301
12. Guldiken S, Guldiken B, Demir M, Kabayel L, Ozkan H, Turgut
N et al (2011) Soluble CD40 ligand and prolactin levels in
migraine patients during interictal period. J Headache Pain
12(3):355–360 PubMed PMID: 21331754. Pubmed Central
PMCID: 3094677
13. Singleton JR, Smith AG, Bromberg MB (2001) Increased prev-
alence of impaired glucose tolerance in patients with painful
sensory neuropathy. Diabetes Care 24(8):1448–1453
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E,
Pellikka PA et al (2005) Recommendations for chamber quanti-
fication: a report from the American society of echocardiogra-
phy’s guidelines and standards committee and the chamber
quantification writing group, developed in conjunction with the
European association of echocardiography, a branch of the
European society of cardiology. J Amer Soc Echocardio
18(12):1440–1463 PubMed PMID: 16376782
15. Ayhan S, Ozturk S, Alcelik A, Ozlu MF, Erdem A, Memioglu T
et al (2012) Atrial conduction time and atrial mechanical function
in patients with impaired fasting glucose. J Interv Cardiac Elec-
trophysiol 35(3):247–252 discussion 52. PubMed PMID:
2301138
16. Dilaveris PE, Gialafos JE (2001) P-wave dispersion: a novel
predictor of paroxysmal atrial fibrillation. Ann Noninvasv Elec-
trocardiol 6(2):159–165
Table 3 ROC analysis, diagnostic measures and Kappa test results of variables in the detection of atrial conduction abnormalities in migraine
patients
Variables ROC analysis Diagnostic measures Kappa test
AUC (95 % CI) Cutoff
value
SEN (95 % CI) SPE (95 % CI) PPV (95 % CI) NPV (95 % CI) j p
PA lateral 0.76 (0.65–0.86)ab [56 0.84 (0.71–0.94) 0.62 (0.41–0.80) 0.79 (0.65–0.90) 0.70 (0.47–0.87) 0.471 \0.001
PA septal 0.66 (0.54–0.77)b [36 0.87 (0.73–0.95) 0.54 (0.33–0.73) 0.76 (0.63–0.87) 0.70 (0.45–0.89) 0.426 \0.001
Interatrial
delay
0.83 (0.73–0.91)a [18 0.87 (0.73–0.95) 0.65 (0.44–0.83) 0.81 (0.67–0.91) 0.74 (0.51–0.90) 0.534 \0.001
Intraatrial
delay
0.80 (0.69–0.89)a [5 0.89 (0.76–0.96) 0.62 (0.41–0.80) 0.80 (0.66–0.90) 0.76 (0.53–0.92) 0.526 \0.001
Pd 0.67 (0.55–0.78)b [34 0.89 (0.76–0.96) 0.38 (0.20–0.59) 0.71 (0.58–0.83) 0.67 (0.38–0.88) 0.300 0.007
Different superscripts indicate statistically significant differences
AUC Area under curve, CI confidence interval, SEN sensitivity, SPE specificity, PPV positive predictive value, NPV negative predictive value, jKappa statistic
Acta Neurol Belg
123
17. Can I, Onat AM, Aytemir K, Akdogan A, Ureten K, Kiraz S et al
(2007) Assessment of atrial conduction in patients with sclero-
derma by tissue Doppler echocardiography and P wave disper-
sion. Cardiology 108(4):317–321
18. Yavuzkir M, Ozturk A, Dagli N, Koca S, Karaca I, Balin M et al
(2007) Effect of ongoing inflammation in rheumatoid arthritis on
P-wave dispersion. J Intern Med Res 35(6):796–802 PubMed
PMID: 18034993
19. Karabag T, Aydin M, Dogan SM, Koca R, Buyukuysal C, Sayin
MR et al (2012) Investigation of the atrial electromechanical
delay duration in Behcet patients by tissue Doppler echocardi-
ography. European Heart J Cardiovasc Imag 13(3):251–256
20. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ,
Papanikolaou V, Poralis K et al (2000) Clinical and
electrocardiographic predictors of recurrent atrial fibrillation.
Pacing Clin Electrophysiol 23(3):352–358
21. Dogdu O, Yarlioglues M, Kaya MG, Ardic I, Kilinc Y, Elcik D
et al (2011) Assessment of atrial conduction time in patients with
systemic lupus erythematosus. J Invest Med 59(2):281–286
22. Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G,
Koroglu S et al (2009) Assessment of atrial conduction time in
patients with familial Mediterranean fever. Pacing Clin Electro-
physiol 32(3):308–313
23. Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Altun B
et al (2009) Assessment of atrial electromechanical coupling
characteristics in patients with ankylosing spondylitis. Echocar-
diography 26(5):549–557
Acta Neurol Belg
123